{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:36:17Z","timestamp":1772552177164,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T00:00:00Z","timestamp":1333929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034646","type":"journal-article","created":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T16:51:37Z","timestamp":1333990297000},"page":"e34646","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models"],"prefix":"10.1371","volume":"7","author":[{"given":"Fang","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zumin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qichao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000658-197203000-00014","article-title":"Anti-angiogenesis: new concept for therapy of solid tumors.","volume":"175","author":"J Folkman","year":"1972","journal-title":"Ann Surg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases.","volume":"407","author":"P Carmeliet","year":"2000","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy.","volume":"7","author":"RK Jain","year":"2001","journal-title":"Nature Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target.","volume":"438","author":"N Ferrara","year":"2005","journal-title":"Nature"},{"key":"ref5","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.","volume":"58","author":"JM Brown","year":"1998","journal-title":"Cancer Research"},{"key":"ref6","first-page":"5863","article-title":"The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce F. Cain Memorial Award lecture.","volume":"59","author":"JM Brown","year":"1999","journal-title":"Cancer Research"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment.","volume":"4","author":"JM Brown","year":"2004","journal-title":"Nature Reviews Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.","volume":"307","author":"RK Jain","year":"2005","journal-title":"Science"},{"key":"ref9","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.","volume":"6","author":"F Winkler","year":"2004","journal-title":"Cancer Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2007.05.003","article-title":"Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.","volume":"74","author":"D Fukumura","year":"2007","journal-title":"Microvasc Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1158\/1078-0432.CCR-06-2441","article-title":"Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.","volume":"13","author":"RP Dings","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1158\/0008-5472.CAN-06-4102","article-title":"Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.","volume":"67","author":"RK Jain","year":"2007","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ijrobp.2009.12.010","article-title":"Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation.","volume":"76","author":"MC McGee","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-09-3073","article-title":"Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas.","volume":"16","author":"SS Chae","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"17505","DOI":"10.1073\/pnas.0908026106","article-title":"Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature.","volume":"106","author":"EM Hedlund","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e6539","DOI":"10.1371\/journal.pone.0006539","article-title":"Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy.","volume":"4","author":"GJ Cerniglia","year":"2009","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejca.2010.10.026","article-title":"Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.","volume":"47","author":"AW Lee","year":"2011","journal-title":"European Journal of Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2174\/156800910791859506","article-title":"ZD6474, a small molecule tyrosine kinase inhibitor, potentiates the anti-tumor and anti-metastasis effects of radiation for human nasopharyngeal carcinoma.","volume":"10","author":"S Yang","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.","volume":"88","author":"MS O'Reilly","year":"1997","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.06.155","article-title":"Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR\/Flk-1 of endothelial cells.","volume":"361","author":"Y Ling","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","first-page":"654S","article-title":"Results of phase III trial of rh-endostatin (YH-16) in advanced non-small cell lung cancer (NSCLC) patients.","volume":"23","author":"Y Sun","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.2910310509","article-title":"Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma.","volume":"31","author":"Z Sizhong","year":"1983","journal-title":"Int J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-06-0094","article-title":"Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.","volume":"66","author":"LB Song","year":"2006","journal-title":"Cancer Res"},{"key":"ref24","first-page":"1452","article-title":"A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: Implications for radiosensitization and EBV-targeted therapy.","volume":"6","author":"YL Chung","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1074\/jbc.M109.048397","article-title":"Stem-like cancer cells are inducible by increasing genomic instability in cancer cells.","volume":"285","author":"Y Liang","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1172\/JCI32479","article-title":"Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.","volume":"117","author":"LJ Nissen","year":"2007","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2004.08.034","article-title":"PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis.","volume":"6","author":"R Cao","year":"2004","journal-title":"Cancer Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00280-008-0729-3","article-title":"Her2\/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2\/neu(+) tumors.","volume":"63","author":"M Hardee","year":"2009","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/1078-0432.CCR-07-4544","article-title":"Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide.","volume":"14","author":"QY Zhou","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00595-009-4020-y","article-title":"TSU68, an antiangiogenic receptor tyrosine kinase inhibitor, induces tumor vascular normalization in a human cancer xenograft nude mouse model.","volume":"39","author":"M Ohta","year":"2009","journal-title":"Surg Today"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1349-7006.2007.00724.x","article-title":"Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.","volume":"99","author":"E Taguchi","year":"2008","journal-title":"Cancer Sci"},{"key":"ref32","first-page":"261","author":"RK Jain","year":"2008"},{"key":"ref33","first-page":"3356","article-title":"Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models.","volume":"119","author":"F Maione","year":"2009","journal-title":"J Clin Invest"},{"key":"ref34","first-page":"5516","article-title":"Phase II study of chemoradiation plus bevacizumab (BV) for locally\/regionally advanced nasopharyngeal carcinoma (NPC): Preliminary clinical results of RTOG 0615.","volume":"29","author":"NY Lee","year":"2011","journal-title":"2011 ASCO Annual Meeting"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.","volume":"10","author":"P Carmeliet","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.","volume":"20","author":"HF Dvorak","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molmed.2006.08.009","article-title":"PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.","volume":"12","author":"ET Ek","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.","volume":"285","author":"DW Dawson","year":"1999","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"9492","DOI":"10.1074\/jbc.M108004200","article-title":"Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5.","volume":"277","author":"G Gao","year":"2002","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling.","volume":"8","author":"A Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment.","volume":"141","author":"K Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.04.032","article-title":"Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism.","volume":"614","author":"Q Ni","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3181\/0801-RM-7","article-title":"Endostar suppresses invasion through downregulating the expression of matrix metalloproteinase-2\/9 in MDA-MB-435 human breast cancer cells.","volume":"233","author":"N Lu","year":"2008","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T12:38:14Z","timestamp":1540298294000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034646"}},"subtitle":[],"editor":[{"given":"Ramani","family":"Ramchandran","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,9]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034646","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,9]]}}}